Granules India strengthens oversight after US FDA warning on manufacturing violations

economictimes.indiatimes.com

Granules India is enhancing oversight and digitizing records at its manufacturing facilities following a U.S. FDA warning about violations. The U.S. regulator cited issues with record-keeping and contamination control at the company's largest plant, a significant revenue source. The company is implementing automation and stricter controls, with the FDA expected to conduct further inspections soon.


With a significance score of 2.2, this news ranks in the top 22% of today's 32836 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers:


Granules India strengthens oversight after US FDA warning on manufacturing violations | News Minimalist